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Although the field of travel medi-
cine is relatively young, the number of
textbooks about the field is growing.
This international trio of authors from
Switzerland, the United States, and
Singapore, recently published the sec-
ond edition of their textbook, which
adds new chapters and updates epi-
demiologic information. Because of
the complexity of travel medicine,
good resources for clinicians and trav-
elers are needed. This edition repre-
sents a welcome addition to the library
of travel medicine.
The main audience for this text-
book is travel medicine physicians.
Like the first edition, it is designed to
be a reference book. Although small
enough to fit in a pocket of a white
coat, this paperback is very readable
and comes with an easy-to-use CD. 
Part 1 of the book, Basics, provides
an overview of general topics for
physicians to discuss with their travel-
ing patients. The authors encourage a
comprehensive strategy, one that dis-
cusses prevention measures such as
vaccines and their appropriate uses.
Appendix C is an excellent table that
lists the required and recommended
vaccinations for each country. The text
also provides excellent information for
travelers in varied situations, such as
pilgrims to the Hajj, migrants, preg-
nant women, international adoptees,
athletes, and persons who are
immunocompromised.
In addition to providing current
information on immunizations, the
authors provide thorough information
on malaria, including some individual
country maps displaying areas of risk.
Although the malaria review is com-
prehensive, caution should be exer-
cised when deciding not to provide
prophylaxis for travelers to a country
where malaria is endemic.
Part 2, Infectious Health Risks and
Their Prevention, is the familiar
chronicle of travel-related infectious
diseases. This section includes numer-
ous maps and tables describing the
epidemiology of the diseases. The
authors have updated this part by
adding several diseases, including
severe acute respiratory syndrome.
The book provides pertinent infor-
mation on travelers’ medical kits,
water disinfection, and noninfectious
health risks such as high altitude, arc-
tic travel, diving, jet lag, and ultravio-
let radiation. New for this edition are
informative chapters on deep vein
thrombosis and pulmonary embolism
and in-flight accidents.
Another strength of this work is
the section on posttravel medical
treatment. This chapter presents con-
cise guidelines for the clinician who is
treating posttravel patients (with diar-
rhea, fever, malaria, dermatologic dis-
orders, eosinophilia, sexually trans-
mitted diseases) or screening expatri-
ates after prolonged stays in tropical
regions. A particularly useful feature
is the dosing recommendations, many
of which are for infrequently used
drugs. 
In conclusion, the Manual of
Travel Medicine and Health, Second
Edition, should be a useful textbook
for travel medicine physicians and
those in training who want to learn
more about the field. While the tradi-
tional topics are covered in customary
detail, the strength of the book is its
comprehensiveness and portability,
providing a convenient reference.
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Few fields in medical science
involve as wide a range of specialties
and expertise as vaccinology. It
encompasses the research, develop-
ment, and manufacturing processes of
vaccines, their incorporation into
immunization programs, and the
logistic and clinical aspects of their
use. Commissioning experts to write
chapters with a minimum of jargon,
minutiae, and redundancy, for a book
with a target audience of immunolo-
gists, microbiologists, clinical trial
specialists, epidemiologists, econo-
mists, policy-setting public health
officials, and practitioners who
administer the resulting products and
provide follow-up care, is challeng-
ing. But the experienced editors of
this book have achieved this goal. Dr.
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Bloom was previously a Myco-
bacterium immunologist at the Albert
Einstein School of Medicine and is
now dean of the Harvard School of
Public Health. Dr. Lambert is a vac-
cine immunologist at the University
of Geneva. 
The Vaccine Book first covers the
impact of disease, including chapters
on vaccine economics and finance
policy, and the potential for wide-
spread vaccination to change the epi-
demiology of the target disease. One
example is the herd effect of child-
hood rubella vaccination, which post-
pones infection in nonimmunized
women into their childbearing years.
The next section reviews the immune
system, and here lies the book's great-
est disappointment. Its chapter on
basic immunology is confusing and
presumes familiarity with terms and
concepts without antecedent explana-
tion. It lacks a logical flow in describ-
ing what is yet known of the (infinite-
ly?) complex immune system and its
many "up-" and "down-regulating"
feedback loops. Readers hoping for a
chapter-length "Immunology 101"
course would be advised to turn else-
where (1,2).
The phased stages of clinical trials
are covered in excellent chapters by
accomplished authors with practical
insights. Another section shows how
knowledge of microbial pathogenesis
can affect vaccine design, including
Rolf Zinkernagel's well-written chap-
ter on immunologic memory. Another
chapter on parasite pathogenesis,
however, delves too deeply into the
immunity of Leishmania as a case
study. 
Stanley Plotkin's thoughtful
overview of the 11 disease-specific
chapters annotates new vaccine tech-
nologies as well as current issues of
debate, such as replacing the live oral
polio vaccine worldwide with
injectable, inactivated polio vaccine
once the eradication program breaks
the chain of wild-virus circulation, to
avoid reverse mutations and resulting
vaccine-associated paralysis. Plotkin
also provides a comprehensive table
of vaccine types currently available or
in active clinical development. 
Remaining sections of The
Vaccine Book cover the ethics of
research and use of vaccines, their
safety and controversies, and their
introduction into healthcare systems.
The editors conclude with major
future challenges, such as circumvent-
ing microbial escape, vaccines for
chronic and autoimmune diseases,
and maintaining public support of
immunization in the face of antivac-
cine movements.
The breadth of vaccinology
inevitably requires leaving out some
topics. There is no chapter on measles
vaccines, used universally for a major
cause of childhood death and disabili-
ty. Manufacturing steps such as fer-
mentation, purification, formulation,
fill, and finish are not described.
There is little on quality assurance and
regulation, such as the investigational
new drug application process and cur-
rent good manufacturing practice,
although good clinical practice is
mentioned. Despite these gaps, com-
pared to this field's authoritative ency-
clopedia (3), at three times The
Vaccine Book's mass and four times
its pages, this handy 1.1-kg compila-
tion is a more comfortable read,
indeed. 
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